Onconetix, Inc. (ONCO): Shareholders' Equity
$15.76M
As of 2025-12-31
$13.47M
As of 2026-06-30
-11.0%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $15.76M | +84.5% | 2026-03-13, Balance as of period end |
| 2024-12-31 | $8.54M | +508.2% | 2026-03-13, Balance as of period end |
| 2023-12-31 | $1.40M | -93.7% | 2025-06-02, Balance as of period end |
| 2022-12-31 | $22.39M | n/m | 2024-04-11, Balance as of period end |
| 2021-12-31 | $1.45M | n/a | 2023-03-09, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | 2025-12-31 | $15.76M | +84.5% |
| Rallybio Corp (RLYB) | 2025-12-31 | $57.96M | -6.0% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $98.37M | +14.0% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $2.99M | -62.8% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $82.39M | +3.5% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $3.46M | -14.2% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | -$1.22M | n/m |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $2.84M | n/m |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | -$95.46M | n/m |
Compare ONCO, RLYB, RFL, LEXX side by side · Screen every company in Pharmaceutical Preparations ↗